Phenylpyruvic acid

From WikiMD's Wellness Encyclopedia

Error creating thumbnail:
Phenylpyruvic acid

0Phenylpyruvic acid (PPA) is an organic compound with the formula C6H5CH2COCOOH. It is a keto acid, structurally derived from phenylalanine via the removal of an amino group through the process of transamination. Phenylpyruvic acid is a key player in various metabolic pathways and is associated with certain metabolic disorders, most notably Phenylketonuria (PKU).

Chemical Structure and Properties[edit | edit source]

Phenylpyruvic acid is a white, crystalline solid at room temperature. It is soluble in water and alcohol, but insoluble in ether and benzene. The compound has a molar mass of 164.17 g/mol and a melting point of 79-81 °C. Its chemical structure consists of a benzene ring attached to a pyruvic acid molecule, hence the name phenylpyruvic acid.

Biosynthesis[edit | edit source]

Phenylpyruvic acid is biosynthesized from phenylalanine through the process of transamination. This process is catalyzed by the enzyme phenylalanine transaminase, which transfers an amino group from phenylalanine to a ketone or aldehyde, resulting in the formation of phenylpyruvic acid and glutamate.

Role in Metabolic Pathways[edit | edit source]

Phenylpyruvic acid plays a crucial role in various metabolic pathways. It is a key intermediate in the phenylalanine metabolism pathway, where it is converted into tyrosine by the enzyme phenylalanine hydroxylase. Tyrosine is then further metabolized into various important biomolecules, including dopamine, norepinephrine, and epinephrine.

Clinical Significance[edit | edit source]

Phenylpyruvic acid is clinically significant as its accumulation in the body can lead to phenylketonuria, a metabolic disorder characterized by the inability to metabolize phenylalanine. This results in the buildup of phenylpyruvic acid in the blood and urine, leading to intellectual disability, seizures, and other serious health problems if left untreated. The condition is typically diagnosed through newborn screening tests and can be managed through a diet low in phenylalanine.

See Also[edit | edit source]




This metabolic disorder related article is a stub. You can help WikiMD by expanding it.

Contributors: Prab R. Tumpati, MD